DEFA5 and colorectal carcinoma: Based on gene expression results, an ROC curve analysis revealed that CK20, DEFA5, and LAD1 are not suited as blood-based biomarkers allowing for a reliable and specific discrimination of a CRC from benign colorectal diseases or healthy individuals.